Abstract:Abstract: Treatment of cancer, one of the most fatal diseases in the present century, has become a topic of global concern. Unfavorable unintentional effects of chemotherapy and radiation treatments have been the main reasons for the research on the discovery of drugs with a broader spectrum of effectiveness and efficiency, with minimal side effects. Curcumin (diferuloylmethane) is a naturally occurring phenolic structure with anticancer properties through its inhibition of cell multiplication, metastasis, and prolongation of cell cycle suppression of apoptosis in various tumor cells. The primary restriction regarding the use of curcumin in cancer treatment is related to poor bioavailability and unfavorable pharmacokinetic profiles of curcumin due to its poor absorption rate, fast metabolism, and systemic elimination. A variety of ways have been proposed to overcome these limitations. With this background, the present study focuses on providing a comprehensive overview of the anticancer properties of curcumin derivatives and the synthesis of curcumin analogs with application to different types of cancers. The regulation of various target and signaling pathways is considered in various cancers, including breast, gastrointestinal, pancreatic, prostate, skin, and lung cancers. A review of the literature indicates that modifying the structure of curcumin through the substitution of the phenyl group and unsaturated carbon branch around the two main sites of oxygen can result in the improvement of physical and chemical properties, as well as the enhancement of physiological activities of the curcumin molecule and the anti-cancer activities of this polyphenol. Curcumin analogs demonstrate anticancer properties at multiple targets at different cell stages and by various signaling biochemical pathways. These include cytokines, transcription factors, growth factors, and modulation of genes involved in cellular proliferation and apoptosis in breast, gastrointestinal, skin, prostate, and lung cancers, thereby mitigating tumor progression.

Curcumin and Cancer

Curcumin Targets in Inflammation and Cancer

Role of the Dietary Phytochemical Curcumin in Targeting Cancer Cell Signalling Pathways

Curcumin and Related Compounds in Cancer Cells: New Avenues for Old Molecules

The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management

Curcumin and cancer biology: Focusing regulatory effects in different signalling pathways

Curcumin and its formulations: potential anti-cancer agents.

A Review of Curcumin and Its Derivatives as Anticancer Agents

Curcumin: The story so far

Ancient Drug Curcumin Impedes 26S Proteasome Activity by Direct Inhibition of Dual-Specificity Tyrosine-Regulated Kinase 2

Curcumin: An Insight into Molecular Pathways Involved in Anticancer Activity

The Cancer Chemopreventive and Therapeutic Potential of Tetrahydrocurcumin

Curcumin As a Therapeutic Agent in Cancer Therapy: Focusing on Its Modulatory Effects on Circularrnas

Curcumin Regulates Cancer Progression: Focus on ncRNAs and Molecular Signaling Pathways

Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression

Synthetic Curcumin Analogs in the Treatment of Cancer: A Literature Review

Regulation of Polyamine Metabolism by Curcumin for Cancer Prevention and Therapy.

An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management

Curcumin: reclaiming the lost ground against cancer resistance

Curcumin in cancer therapy: Exploring molecular mechanisms and overcoming clinical challenges

The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway